Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-01-21
1993-06-29
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
052235076
ABSTRACT:
The present invention provides a method for eliminating or ameliorating pain in an animal comprising administrating a therapeutically-effective amount of a substituted morphinoid compound of Formula I: ##STR1## The compounds are opioid agonists which are useful as analgesic agents for the treatment of pain.
REFERENCES:
patent: 4816586 (1989-03-01), Portoghese
Portoghese et al. Design of Peptidomimetic Delta Opioid Receptor etc. 33 1714-1720 Jan. 1990.
Portoghese et al. Application of the Message-Address Concept in etc. 31, No. 2 281-282 Jan. 1988.
Dappen Michael S.
Pitzele Barnett S.
Rafferty Michael F.
G. D. Searle & Co.
Hastreiter Roberta L.
Henley III Raymond J.
Matukaitis Paul D.
Waddell Frederick E.
LandOfFree
Method of using opioid compounds as delta opioid selective agoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using opioid compounds as delta opioid selective agoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using opioid compounds as delta opioid selective agoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755638